The pGFAP level was significantly correlated with AD-specific CSF biomarkers, such as the Aβ42/Aβ40 ratio, amyloid-PET centiloid, total tau and phosphorylated tau in the whole sample, but these correlations were not significant within diagnostic subgroups (Additional file 2). Here, MAPT is linked to Alzheimer disease.